Article Information
History
- September 4, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- 1Department of Pharmacy, College of Medicine and Health Sciences, Ambo University, P.O. Box 19, Ambo; Ethiopia
- 2College of Health Science, Assosa University, P.O. Box 18 (Assosa University (ASU)); Assosa, Ethiopia
- 3Pharm-Biotechnology and Traditional Medicine Center of Excellence, Mbarara University of Science and Technology, Mbarara, Uganda
- 4School of Pharmacy, Faculty of Medicine, Hawassa University, P. O. Box 1560, Hawassa; Ethiopia
- ↵*Corresponding Author: Department of Pharmacy, College of Medicine and Health Sciences, Ambo University, P.O. Box 19, Ambo; Ethiopia E-mail; tamiratbekele12{at}gmail.com; tbekele{at}std.must.ac.ug Tel; +256 753 415 022/+251966736947
Posted September 04, 2020.
Effect of Renin-Angiotensin-Aldosterone System inhibitors on outcomes of COVID-19 patients with hypertension: Systematic review and Meta-analysis
